| Primary |
| Cough |
16.1% |
| Bronchitis |
12.9% |
| Product Used For Unknown Indication |
12.9% |
| Upper Respiratory Tract Infection |
9.7% |
| Drug Use For Unknown Indication |
6.5% |
| Glaucoma |
6.5% |
| Nasal Congestion |
6.5% |
| Respiratory Tract Infection |
6.5% |
| Asthma |
3.2% |
| Lower Respiratory Tract Infection |
3.2% |
| Nasopharyngitis |
3.2% |
| Respiratory Tract Congestion |
3.2% |
| Sinusitis |
3.2% |
| Thyroid Disorder |
3.2% |
| Viral Infection |
3.2% |
|
| Urticaria |
13.8% |
| Vomiting |
10.3% |
| Drug Abuse |
6.9% |
| Drug Hypersensitivity |
6.9% |
| Rash |
6.9% |
| Toxicity To Various Agents |
6.9% |
| Abdominal Discomfort |
3.4% |
| Anaphylactic Reaction |
3.4% |
| Angioedema |
3.4% |
| Choking |
3.4% |
| Completed Suicide |
3.4% |
| Defaecation Urgency |
3.4% |
| Drug Dispensing Error |
3.4% |
| Drug Ineffective |
3.4% |
| Dyspnoea |
3.4% |
| Epistaxis |
3.4% |
| Gastrooesophageal Reflux Disease |
3.4% |
| Haematemesis |
3.4% |
| Haemoptysis |
3.4% |
| Hypersensitivity |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
56.5% |
| Pneumonia |
8.8% |
| Nasopharyngitis |
8.5% |
| Drug Use For Unknown Indication |
6.2% |
| Influenza |
2.4% |
| Suicide Attempt |
2.4% |
| Cough |
2.1% |
| Hypertension |
2.1% |
| Anxiety Disorder |
1.2% |
| Bronchitis |
1.2% |
| Chronic Obstructive Pulmonary Disease |
1.2% |
| Pharyngitis |
1.2% |
| Rheumatoid Arthritis |
1.2% |
| Cholelithiasis |
0.9% |
| Dyspnoea |
0.9% |
| Headache |
0.9% |
| Sinus Congestion |
0.9% |
| Antibiotic Prophylaxis |
0.6% |
| Arthralgia |
0.6% |
| Diabetes Mellitus Non-insulin-dependent |
0.6% |
|
| Completed Suicide |
21.7% |
| Toxicity To Various Agents |
13.3% |
| Death |
11.7% |
| Urinary Retention |
6.7% |
| Chest Pain |
3.3% |
| Cough |
3.3% |
| Dehydration |
3.3% |
| Drug Hypersensitivity |
3.3% |
| Pharyngeal Oedema |
3.3% |
| Pulmonary Oedema |
3.3% |
| Respiration Abnormal |
3.3% |
| Swollen Tongue |
3.3% |
| Syncope |
3.3% |
| Vestibular Disorder |
3.3% |
| Visual Impairment |
3.3% |
| Vomiting |
3.3% |
| Adverse Event |
1.7% |
| Blood Glucose Increased |
1.7% |
| Chest Discomfort |
1.7% |
| Chills |
1.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.9% |
| Drug Use For Unknown Indication |
22.8% |
| Pain |
5.7% |
| Hypertension |
3.7% |
| Asthma |
3.3% |
| Cough |
3.0% |
| Depression |
2.4% |
| Chronic Obstructive Pulmonary Disease |
2.4% |
| Nausea |
2.1% |
| Hypersensitivity |
2.0% |
| Anxiety |
2.0% |
| Constipation |
1.9% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Prophylaxis |
1.7% |
| Rheumatoid Arthritis |
1.5% |
| Multiple Myeloma |
1.5% |
| Non-small Cell Lung Cancer |
1.5% |
| Arthritis |
1.4% |
| Adverse Event |
1.3% |
| Dyspnoea |
1.3% |
|
| Vomiting |
12.2% |
| Weight Decreased |
8.0% |
| Urinary Tract Infection |
7.1% |
| Weight Increased |
6.4% |
| Pneumonia |
5.4% |
| Wheezing |
5.2% |
| White Blood Cell Count Decreased |
5.2% |
| Sinusitis |
4.7% |
| Drug Ineffective |
4.5% |
| Pulmonary Embolism |
4.5% |
| Dyspnoea |
4.2% |
| Pain |
4.2% |
| Death |
4.0% |
| White Blood Cell Count Increased |
4.0% |
| Myocardial Infarction |
3.5% |
| Nausea |
3.5% |
| Respiratory Failure |
3.5% |
| Type 2 Diabetes Mellitus |
3.3% |
| Upper Respiratory Tract Infection |
3.3% |
| Vision Blurred |
3.3% |
|
| Interacting |
| Drug Use For Unknown Indication |
66.7% |
| Anxiety Disorder |
33.3% |
|
| Heart Rate Increased |
50.0% |
| Pulmonary Oedema |
50.0% |
|
